Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Carcinoma, Renal Cell 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neuroendocrine Tumors (pNET) 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

pembrolizumab 2 enfortumab vedotin 1 Watchful Waiting 1 Specimen Handling 1 Observation 1 Magnetic Resonance Spectroscopy 1 Cystoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ureteral Neoplasms × Watchful Waiting × 30 days × Clear all

NCT03244384 2026-05-29

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡